BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved ...

MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a Pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of BIJUVA ® (estradiol ...

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved BIJUVA ™ (estradiol and progesterone) capsules, 1 ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Progesterone Capsules, 100 mg and 200 mg, ...

Menopause is a process that takes place over several years and usually begins in the early 50s. Studies show that estrogens, commonly prescribed in menopause, maintain the woman's bone structure and ...

Postmenopausal women who experience bothersome hot flashes or night sweats may have an alternative treatment to estrogen. According to a new study, oral micronized progesterone relieves those symptoms ...

Details concerning the Progesterone (Natural Micronized) medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

prometrium label Virtus has announced the launch of Prometrium (progesterone USP capsule). Virtus has announced the launch of Prometrium (progesterone USP capsule). The product is indicated for use in ...

Drug firm Dr Reddy's today said it has launched generic Progesterone capsules used in treatment of menstrual irregularities and protection of the lining of uterus in the US market. The product has ...

12 December 2022 – Besins Healthcare UK has announced that Utrogestan 100mg has been accepted for use within NHS Scotland for adjunctive use with oestrogen in post-menopausal women with an intact ...

The first and only licensed treatment in the UK for the prevention of miscarriage in women with early pregnancy bleeding and a history of recurrent miscarriage LONDON, UK. 1 APRIL 2025 – Besins ...